Alhumaid N, Tawfik E
Int J Mol Sci. 2024; 25(18).
PMID: 39337622
PMC: 11432040.
DOI: 10.3390/ijms251810139.
Nchourupouo K, Nde J, Ngouongo Y, Zekeng S, Fongang B
Molecules. 2023; 28(4).
PMID: 36838825
PMC: 9966702.
DOI: 10.3390/molecules28041838.
Scardino V, Di Filippo J, Cavasotto C
iScience. 2023; 26(1):105920.
PMID: 36686396
PMC: 9852548.
DOI: 10.1016/j.isci.2022.105920.
Temirak A, Schlegel J, Voss J, Vaassen V, Vielmuth C, Claff T
Molecules. 2022; 27(12).
PMID: 35744918
PMC: 9231011.
DOI: 10.3390/molecules27123792.
Kapla J, Rodriguez-Espigares I, Ballante F, Selent J, Carlsson J
PLoS Comput Biol. 2021; 17(5):e1008936.
PMID: 33983933
PMC: 8186765.
DOI: 10.1371/journal.pcbi.1008936.
A unique ligand-steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure-based virtual screening.
Jin H, Xia J, Liu Z, Wang X, Zhang L
Chem Biol Drug Des. 2021; 97(4):944-961.
PMID: 33386704
PMC: 8048943.
DOI: 10.1111/cbdd.13820.
Adenosine A receptor antagonists: from caffeine to selective non-xanthines.
Jacobson K, Gao Z, Matricon P, Eddy M, Carlsson J
Br J Pharmacol. 2020; 179(14):3496-3511.
PMID: 32424811
PMC: 9251831.
DOI: 10.1111/bph.15103.
Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
Jaiteh M, Rodriguez-Espigares I, Selent J, Carlsson J
PLoS Comput Biol. 2020; 16(3):e1007680.
PMID: 32168319
PMC: 7135368.
DOI: 10.1371/journal.pcbi.1007680.
Influence of the Structural Accuracy of Homology Models on Their Applicability to Docking-Based Virtual Screening: The β Adrenergic Receptor as a Case Study.
Costanzi S, Cohen A, Danfora A, Dolatmoradi M
J Chem Inf Model. 2019; 59(7):3177-3190.
PMID: 31257873
PMC: 6800073.
DOI: 10.1021/acs.jcim.9b00380.
Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking.
Wagner J, Churas C, Liu S, Swift R, Chiu M, Shao C
Structure. 2019; 27(8):1326-1335.e4.
PMID: 31257108
PMC: 6685748.
DOI: 10.1016/j.str.2019.05.012.
Dual binding mode of "bitter sugars" to their human bitter taste receptor target.
Fierro F, Giorgetti A, Carloni P, Meyerhof W, Alfonso-Prieto M
Sci Rep. 2019; 9(1):8437.
PMID: 31186454
PMC: 6560132.
DOI: 10.1038/s41598-019-44805-z.
Understanding Ligand Binding to G-Protein Coupled Receptors Using Multiscale Simulations.
Alfonso-Prieto M, Navarini L, Carloni P
Front Mol Biosci. 2019; 6:29.
PMID: 31131282
PMC: 6510167.
DOI: 10.3389/fmolb.2019.00029.
A benchmark study of loop modeling methods applied to G protein-coupled receptors.
Wink L, Baker D, Cole J, Parrill A
J Comput Aided Mol Des. 2019; 33(6):573-595.
PMID: 31123958
PMC: 6628340.
DOI: 10.1007/s10822-019-00196-x.
Evaluating the performance of MM/PBSA for binding affinity prediction using class A GPCR crystal structures.
Yau M, Emtage A, Chan N, Doughty S, Loo J
J Comput Aided Mol Des. 2019; 33(5):487-496.
PMID: 30989574
DOI: 10.1007/s10822-019-00201-3.
Comparative Modeling and Evaluation of Leukotriene B4 Receptors for Selective Drug Discovery Towards the Treatment of Inflammatory Diseases.
Ibrahim M, Hassan A
Protein J. 2018; 37(6):518-530.
PMID: 30267300
DOI: 10.1007/s10930-018-9797-3.
Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1.
Rexen Ulven E, Trauelsen M, Brvar M, Luckmann M, Bielefeldt L, Jensen L
Sci Rep. 2018; 8(1):10010.
PMID: 29968758
PMC: 6030209.
DOI: 10.1038/s41598-018-28263-7.
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.
Lemos A, Melo R, Preto A, Almeida J, Moreira I, Cordeiro M
Curr Neuropharmacol. 2018; 16(6):786-848.
PMID: 29521236
PMC: 6080095.
DOI: 10.2174/1570159X16666180308161642.
Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni.
Hahnel S, Wheeler N, Lu Z, Wangwiwatsin A, McVeigh P, Maule A
PLoS Pathog. 2018; 14(1):e1006718.
PMID: 29346437
PMC: 5773224.
DOI: 10.1371/journal.ppat.1006718.
Computer-aided design of multi-target ligands at AR, AR and PDE10A, key proteins in neurodegenerative diseases.
Kalash L, Val C, Azuaje J, Loza M, Svensson F, Zoufir A
J Cheminform. 2018; 9(1):67.
PMID: 29290010
PMC: 5748027.
DOI: 10.1186/s13321-017-0249-4.
Assessment of the transmembrane domain structures in GPCR Dock 2013 models.
Wang T, Liu H, Duan Y
J Struct Biol. 2017; 201(3):210-220.
PMID: 29174398
PMC: 5820147.
DOI: 10.1016/j.jsb.2017.11.007.